New scanner could help surgeons spot Left-Behind cancer Mid-Operation

NCT ID NCT06676943

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new type of PET-CT scanner that can scan a tumor right after it is removed from the body. Patients with prostate or head and neck cancer received a small amount of radioactive tracer before surgery, which sticks to cancer cells. After removal, the specimen was scanned to see if cancer cells reached the edge (margin). The scan results were compared to standard lab tests to see how accurate the new method is. If it works well, surgeons could use it during operations to make sure they remove all the cancer the first time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
radioactive tracer (fluorodeoxyglucose or similar) injected before surgery
What this could lead to
If successful, this technique could help surgeons see during an operation whether they have removed all the cancer, reducing the need for extra treatments or second surgeries.
What could go wrong
This is a small pilot study with only 57 participants, so results may not apply to all cancer types. The scanner's accuracy needs to be confirmed against standard lab tests, and it may not work for all tumor locations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospitals Coventry and Warwickshire NHS Trust

    Coventry, CV2 2DX, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.